Ruthenium-catalyzed strategies for the synthesis of bioactive heterocycles

Ruthenium-catalyzed transformations have emerged as a versatile platform for the synthesis of structurally diverse and biologically important heterocycles. Owing to its multiple accessible oxidation states, robust coordination chemistry, and broad functional-group tolerance, ruthenium enables unique reactivity that complements other transition metals. This review summarizes recent advances in ruthenium-catalyzed methodologies for constructing bioactive heterocyclic frameworks, emphasizing mechanistic diversity, substrate scope, and synthetic applications. Particular attention is given to C–H activation strategies, which provide atom- and step-economical routes to complex heterocycles. Ruthenium catalysts efficiently promote both directing-group-assisted and directing-group-free C–H functionalization, enabling the synthesis of pharmaceutically relevant scaffolds, including indoles, isoquinolines, pyrroles, and quinazolines, often under mild conditions with high regioselectivity. The review further examines ruthenium-catalyzed annulation reactions involving alkynes, alkenes, and diazo compounds, which offer efficient access to fused and spirocyclic heterocycles commonly found in natural products and therapeutic agents. Cascade and tandem processes are also highlighted for their ability to rapidly increase molecular complexity while minimizing synthetic steps and waste. Transfer hydrogenation and borrowing hydrogen methodologies are discussed as sustainable approaches for preparing saturated and partially saturated nitrogen-containing heterocycles without the need for stoichiometric oxidants or reductants. In addition, recent advances in ruthenium-based photocatalysis and electrocatalysis demonstrate new opportunities for environmentally benign heterocycle synthesis through unconventional bond-forming reactions. The review also presents representative applications of ruthenium-catalyzed methodologies in the synthesis of biologically active molecules and clinically relevant compounds, illustrating their impact on medicinal chemistry and drug discovery. Current challenges, including catalyst cost, scalability, and selectivity, are critically evaluated alongside recent developments in recyclable and more efficient catalytic systems. Overall, this review highlights the central role of ruthenium catalysis in modern heterocyclic synthesis and provides a comprehensive perspective on its mechanistic foundations, synthetic utility, and future prospects. By integrating fundamental advances with practical applications, it serves as a valuable resource for researchers developing sustainable and efficient strategies for the synthesis of bioactive heterocycles.